文献速递肝病

Semaphorin 3C 加重肝纤维化

Semaphorin 3C exacerbates liver fibrosis.
PubMed 文献 · Hepatology · 2023-04-15

研究分析患者数据库和肝活检,并用活化肝星状细胞特异性基因敲除小鼠及动物模型,发现 SEMA3C 在肝硬化患者肝样本中富集,在 NASH、酒精性肝炎或 HBV 诱导肝炎患者中高表达可区分纤维化转录组更强的人群,敲除 SEMA3C 或 NRP2 可减轻小鼠肝纤维化。

要点

  • SEMA3C 是活化肝星状细胞的新标志物,在肝硬化患者肝样本中富集。
  • SEMA3C 过表达加重 TGF-β 介导的肌成纤维细胞活化。
  • 活化肝星状细胞中敲除 SEMA3C 或 NRP2 可减轻小鼠肝纤维化。

核心结论

  • SEMA3C 是活化肝星状细胞的新标志物,在获得肌成纤维细胞表型和肝纤维化中起基础性作用。

研究设计与样本

  • 分析公开患者数据库和肝活检,使用活化肝星状细胞特异性基因敲除的转基因小鼠进行离体分析和动物模型。

主要发现

  • SEMA3C 是肝硬化患者肝样本中信号素家族最富集的成员。
  • NASH、酒精性肝炎或 HBV 诱导肝炎患者中 SEMA3C 高表达可区分纤维化转录组更强的人群。
  • SEMA3C 表达在不同小鼠肝纤维化模型和分离活化的肝星状细胞中升高。
  • 活化肝星状细胞中敲除 SEMA3C 降低肌成纤维细胞标志物表达。
  • SEMA3C 过表达加重 TGF-β 介导的肌成纤维细胞活化,表现为 SMAD2 磷酸化和靶基因表达增加。

关键数值与推荐

  • 在分离活化的肝星状细胞中,SEMA3C 受体中仅 NRP2 表达维持。
  • 这些细胞中缺乏 NRP2 降低肌成纤维细胞标志物表达。
  • 活化肝星状细胞中特异性敲除 SEMA3C 或 NRP2 均减轻小鼠肝纤维化。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Chronic liver disease is a growing epidemic, leading to fibrosis and cirrhosis. TGF-β is the pivotal profibrogenic cytokine that activates HSC, yet other molecules can modulate TGF-β signaling during liver fibrosis. Expression of the axon guidance molecules semaphorins (SEMAs), which signal through plexins and neuropilins (NRPs), have been associated with liver fibrosis in HBV-induced chronic hepatitis. This study aims at determining their function in the regulation of HSCs. APPROACH AND RESULTS: We analyzed publicly available patient databases and liver biopsies. We used transgenic mice, in which genes are deleted only in activated HSCs to perform ex vivo analysis and animal models. SEMA3C is the most enriched member of the semaphorin family in liver samples from patients with cirrhosis. Higher expression of SEMA3C in patients with NASH, alcoholic hepatitis, or HBV-induced hepatitis discriminates those with a more profibrotic transcriptomic profile. SEMA3C expression is also elevated in different mouse models of liver fibrosis and in isolated HSCs on activation. In keeping with this, deletion of SEMA3C in activated HSCs reduces myofibroblast marker expression. Conversely, SEMA3C overexpression exacerbates TGF-β-mediated myofibroblast activation, as shown by increased SMAD2 phosphorylation and target gene expression. Among SEMA3C receptors, only NRP2 expression is maintained on activation of isolated HSCs. Interestingly, lack of NRP2 in those cells reduces myofibroblast marker expression. Finally, deletion of either SEMA3C or NRP2, specifically in activated HSCs, reduces liver fibrosis in mice. CONCLUSION: SEMA3C is a novel marker for activated HSCs that plays a fundamental role in the acquisition of the myofibroblastic phenotype and liver fibrosis.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. De Angelis Rigotti F, Wiedmann L, Hubert MO, et al. Semaphorin 3C exacerbates liver fibrosis. Hepatology. 2023. PMID: 37055018. doi:10.1097/HEP.0000000000000407

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。